Mesoblast (Mesoblast) Cyclically Adjusted PS Ratio : (As of Apr. 28, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation

Mesoblast Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Mesoblast's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Cyclically Adjusted PS Ratio Chart

Mesoblast Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

29.97

9.53

18.32

Mesoblast Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															13.75	15.06	18.32	-	-

Competitive Comparison of Mesoblast's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Mesoblast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mesoblast's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mesoblast's Cyclically Adjusted PS Ratio falls into.

Mesoblast Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Mesoblast's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Mesoblast's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Dec. 2023 (Change)	*	Current CPI (Dec. 2023)
	=	0	/	125.6559	*	125.6559
	=	0.000

Current CPI (Dec. 2023) = 125.6559.

Mesoblast Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201306	0.000	95.473	0.000
201312	0.000	97.330	0.000
201406	0.000	98.352	0.000
201412	0.013	99.002	0.017
201503	0.013	99.187	0.016
201506	0.012	99.838	0.015
201509	0.021	100.302	0.026
201512	0.011	100.673	0.014
201603	0.010	100.488	0.013
201606	0.064	100.859	0.080
201609	0.001	101.602	0.001
201612	0.001	102.159	0.001
201703	0.002	102.624	0.002
201706	0.001	102.809	0.001
201709	0.003	103.460	0.004
201712	0.027	104.110	0.033
201803	0.002	104.574	0.002
201806	0.003	104.945	0.004
201809	0.023	105.410	0.027
201812	0.003	105.967	0.004
201903	0.002	105.967	0.002
201906	0.005	106.617	0.006
201909	0.032	107.174	0.038
201912	0.003	107.917	0.003
202003	0.021	108.289	0.024
202006	0.001	106.246	0.001
202009	0.002	107.917	0.002
202012	0.004	108.846	0.005
202103	0.003	109.496	0.003
202106	0.003	110.332	0.003
202109	0.005	111.168	0.006
202112	0.003	112.654	0.003
202203	0.003	115.069	0.003
202206	0.003	117.112	0.003
202209	0.002	119.248	0.002
202212	0.003	121.477	0.003
202303	0.002	123.148	0.002
202306	0.003	124.170	0.003
202309	0.000	125.656	0.000
202312	0.000	125.656	0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Mesoblast (OTCPK:MEOBF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Mesoblast Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Mesoblast's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesoblast (Mesoblast) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

MESO:USA LWB:Germany MSB:Australia

Address

Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000

Website

https://www.mesoblast.com

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.